Defibrillator Market Business Growth To Reach $24,608.3 Million By 2030


Defibrillator Market size was valued at USD 13,168 Million in 2020 and is projected to reach USD 24,608.3 Million by 2030, registering a CAGR of 6.6% from 2021 to 2030

PORTLAND, OREGON, USA, Sept. 19, 2022 / — The emphasis on public access defibrillator (PAD) installation by public and private organizations, the development of advanced defibrillators and the increasing incidence of heart disease global defibrillator market growth. Additionally, increasing adoption of technologically advanced defibrillation devices and increasing demand for quality medical care complement the growth. However, heavy price pressure on market players is restraining the growth of the market. On the other hand, advances in next-generation external defibrillators to improve safety and efficiency present new opportunities in the coming years.

The global Defibrillators Market size was valued at USD 13,168 Million in 2020 and is projected to reach USD 24,608.3 Million by 2030, registering a CAGR of 6.6% from 2021 to 2030.

Download Sample Report –

Advent of automated external defibrillators (AEDs) for public access locations, rising incidence of sudden cardiac arrests, and growing awareness of public access defibrillators across the globe are the major drivers for the growth of the market. The increasing number of application areas of defibrillators coupled with the growing adoption of defibrillation systems (ICDs and external defibrillators) in cardiology is expected to drive the growth of the global defibrillator market. The cost-effectiveness, safety, wide accessibility, and clinical value of preliminary treatment for sudden cardiac arrest are driving technological advancements in this market. In addition, the increase in the number of advanced implantable cardiac defibrillators (S-ICDs, T-ICDs and CRT-Ds) and awareness of the early treatment of life-threatening heart diseases (such as cardiac arrhythmia, ventricular fibrillation and heart failure). sudden cardiac arrest) are expected to further drive the demand for defibrillators globally. However, ignorance, unfavorable healthcare reforms, some issues related to defibrillators (external and implantable) are the limitations that limit the growth of the market.

Covid-19 scenario:

The Covid-19 pandemic has impacted the purchasing capabilities of hospitals, especially smaller hospitals, due to the shift in focus towards purchasing resources to care for Covid-infected patients -19. This has led to canceled or postponed agreements for defibrillators.
Many public and private organizations have stopped or postponed the activities of installing defibrillators in public places due to the possibility of cross-contamination and the containment measures put in place by governments.

Get Detailed Analysis of Impact of COVID-19 on Defibrillators Market –

The report offers detailed segmentation of the global defibrillators market on the basis of product, end-user, and region.

Based on the products, the implantable defibrillator segment accounted for the highest share in 2020, contributing more than half of the total share, and is expected to maintain its leading position during the forecast period. However, the external defibrillator segment is expected to witness the highest CAGR of 7.0% from 2021 to 2030.

On the basis of end-user, the hospital segment held the highest share in 2020, accounting for more than two-thirds of the total global defibrillator market share, and is expected to maintain its leading status during the forecast period. . However, the alternative care segment is estimated to exhibit the fastest CAGR of 8.8% from 2021 to 2030.

For Purchase Inquiry –

Based on region, North America contributed the highest share in 2020, accounting for approximately two-fifths of the total market share, and is expected to continue its revenue dominance by 2030. However , Asia-Pacific is estimated to account for the largest CAGR of 8.2% during the forecast period.

Key players in the global defibrillator market analyzed in the research include Asahi Kasei Corporation, Biotronik SE & Co. KG, Stryker Corporation, Philips Healthcare, Boston Scientific Corporation, Medtronic plc, LivaNova PLC, Nihon Kohden Corporation, Cardiac Science Corporation, and St. Jude Medical, Inc.

We also offer regional and national reports –

Japan defibrillator market
defibrillator market in south korea
Singapore defibrillator market
Defibrillator market in China
Defibrillator market in Indonesia
Australia defibrillator market
Taiwan defibrillator market

“We have also published some syndicated market studies in the same field that you may be interested in. Below is the title of the report for your reference, considering the impact of Covid-19 on this market, which will help you to assess the impact of the pandemic on the short and long-term growth trends of this market.

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business consulting division of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global corporations as well as small and medium enterprises with unparalleled quality of “market research reports” and “business intelligence solutions”. AMR has a focused vision to provide business insights and advice to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services across 11 verticals, including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, semiconductors and electronics, automotive and transport, ICT and media, aerospace and defense and BFSI.

David Correa
Allied Analytics LLP
write to us here
Visit us on social media:


Comments are closed.